[go: up one dir, main page]

TW201610169A - 利用哺乳動物及人類細胞進行之格拉雷姆（ｇｌａｔｉｒａｍｅｒ）乙酸鹽相關藥物產品之生物特徵化 - Google Patents

利用哺乳動物及人類細胞進行之格拉雷姆（ｇｌａｔｉｒａｍｅｒ）乙酸鹽相關藥物產品之生物特徵化 Download PDF

Info

Publication number
TW201610169A
TW201610169A TW104120408A TW104120408A TW201610169A TW 201610169 A TW201610169 A TW 201610169A TW 104120408 A TW104120408 A TW 104120408A TW 104120408 A TW104120408 A TW 104120408A TW 201610169 A TW201610169 A TW 201610169A
Authority
TW
Taiwan
Prior art keywords
acetate
expression
drug substance
group
amount
Prior art date
Application number
TW104120408A
Other languages
English (en)
Chinese (zh)
Inventor
麥可 海登
泰爾 海珊
大衛 雷坎尼
利亞特 哈雅狄尼
伊瑞斯 葛羅斯曼
法迪 喬治 淘費克
莎拉 伊莉莎白 寇理茲
班哲明 詹姆士 塞斯康得
Original Assignee
泰瓦藥品工業有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 泰瓦藥品工業有限公司 filed Critical 泰瓦藥品工業有限公司
Publication of TW201610169A publication Critical patent/TW201610169A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW104120408A 2014-07-01 2015-06-24 利用哺乳動物及人類細胞進行之格拉雷姆（ｇｌａｔｉｒａｍｅｒ）乙酸鹽相關藥物產品之生物特徵化 TW201610169A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462019857P 2014-07-01 2014-07-01
US201462020358P 2014-07-02 2014-07-02
US201462025953P 2014-07-17 2014-07-17
US201462047437P 2014-09-08 2014-09-08
US201462078369P 2014-11-11 2014-11-11
US201562134245P 2015-03-17 2015-03-17
US201562162308P 2015-05-15 2015-05-15

Publications (1)

Publication Number Publication Date
TW201610169A true TW201610169A (zh) 2016-03-16

Family

ID=55020098

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104120408A TW201610169A (zh) 2014-07-01 2015-06-24 利用哺乳動物及人類細胞進行之格拉雷姆（ｇｌａｔｉｒａｍｅｒ）乙酸鹽相關藥物產品之生物特徵化

Country Status (6)

Country Link
EP (1) EP3164710A4 (fr)
CA (1) CA2952849A1 (fr)
IL (1) IL249686A0 (fr)
TW (1) TW201610169A (fr)
UY (1) UY36197A (fr)
WO (1) WO2016004250A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116637123A (zh) * 2023-06-07 2023-08-25 上海市东方医院（同济大学附属东方医院） 敲降或下调C15orf39基因表达的试剂在制备治疗胃癌的药物中的应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45496A (fr) * 2016-06-17 2019-04-24 Hoffmann La Roche Molécules d'acide nucléique pour la réduction de l'arnm de padd5 ou pad7 pour le traitement d'une infection par l'hépatite b
WO2018053109A1 (fr) * 2016-09-14 2018-03-22 Teva Pharmaceutical Industries Ltd. Caractérisation d'expression génique d'un produit médicamenteux associé à l'acétate de glatiramère dans des cellules humaines et de mammifères
CN118048356A (zh) 2017-10-16 2024-05-17 豪夫迈·罗氏有限公司 减少PAPD5和PAPD7 mRNA的核酸分子用于治疗乙型肝炎感染

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010530975A (ja) * 2007-06-21 2010-09-16 モメンタ ファーマシューティカルズ インコーポレイテッド コポリマーアッセイ

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116637123A (zh) * 2023-06-07 2023-08-25 上海市东方医院（同济大学附属东方医院） 敲降或下调C15orf39基因表达的试剂在制备治疗胃癌的药物中的应用
CN116637123B (zh) * 2023-06-07 2024-02-13 上海市东方医院（同济大学附属东方医院） 敲降或下调C15orf39基因表达的试剂在制备治疗胃癌的药物中的应用

Also Published As

Publication number Publication date
EP3164710A4 (fr) 2018-04-11
UY36197A (es) 2016-01-29
CA2952849A1 (fr) 2016-01-07
EP3164710A2 (fr) 2017-05-10
WO2016004250A2 (fr) 2016-01-07
WO2016004250A3 (fr) 2016-03-17
IL249686A0 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
US12043870B2 (en) Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer
Kenna et al. Enrichment of circulating interleukin‐17–secreting interleukin‐23 receptor–positive γ/δ T cells in patients with active ankylosing spondylitis
KR102135601B1 (ko) 탈모 질환의 치료 방법
EP2941274A2 (fr) Caractérisation d'un produit médicamenteux associé à l'acétate de glatiramère
Kap et al. Targeted diet modification reduces multiple sclerosis–like disease in adult marmoset monkeys from an outbred colony
US20190284531A1 (en) Detection of t cell exhaustion or lack of t cell costimulation and uses thereof
Pachman et al. Juvenile dermatomyositis: the association of the TNFα-308A allele and disease chronicity
Paley et al. The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells
TW201610169A (zh) 利用哺乳動物及人類細胞進行之格拉雷姆（ｇｌａｔｉｒａｍｅｒ）乙酸鹽相關藥物產品之生物特徵化
US20170003277A1 (en) Biological characterization of a glatiramer acetate related drug product using mammalian and human cells
Yang et al. Single-cell RNA sequencing uncovers molecular mechanisms of intravenous immunoglobulin plus methylprednisolone in Kawasaki disease: attenuated monocyte-driven inflammation and improved NK cell cytotoxicity
US12416632B2 (en) Methods and kits for evaluating clinical outcomes of autoimmune disease
CN101310183A (zh) 用于脊髓损伤中抗Nogo-A抗体治疗的生物标记
US20240263237A1 (en) T cell transcriptomic profiles in parkinson's disease, and methods and uses thereof
WO2018053109A1 (fr) Caractérisation d'expression génique d'un produit médicamenteux associé à l'acétate de glatiramère dans des cellules humaines et de mammifères
Liu Transcriptional signatures of microglial innate immune memory in models of Parkinson’s and Huntington’s disease
Zavacky Investigating the heterogeneity of tumour-associated macrophages in renal cell carcinoma milieu
Morar Clinical and Immunopathogenetic Aspects of Sarcoidosis
Navarro Barriuso Characterization of biomarkers of the generation and functionality of tolerogenic dendritic cells differentiated with vitamin D3
LA BARBERA THE ROLE OF JAK/STAT INHIBITION IN MODULATING THE INNATE IMMUNE RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS
US20220146500A1 (en) Compositions and methods for enhancing mucosal immunity
Chowdhury Characterizing the Function of B Cells that Accumulate in the Inflamed Central Nervous System in Anti-Myelin Autoimmunity
Haigh Effects of Early Life Environmental Tobacco Smoke Exposure on Pulmonary Immunity
Conway Giant cell arteritis: diagnostic tools, treatment targets, and pathogenic pathways
Dionisio-Santos Ameliorating Alzheimer’s Disease Tau Pathology Through Immunomodulation: A Novel Role for Interleukin 4 and Glatiramer Acetate